未登录

E

Esma S. Yolcu

university of missouri

H指数:31

被引数:3,009

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Immune Biomarkers of Islet Transplant Rejection Revealed by Synthetic Immunological Niche

合成免疫微环境揭示的胰岛移植排斥的免疫生物标志物

Advanced Science

IF14.1

2026-10-080

OAAI

Islets co-engineered with thrombomodulin and CD47 achieve sustained survival in allogeneic recipients without chronic immunosuppression

携带凝血酶调节蛋白和CD47共工程化的胰岛在异体受体内实现持续性存活，且无需慢性免疫抑制

IF6.1

2026-05-080

OA

Elucidating the Mechanisms of SA–4–1BBL-Mediated Cancer Immunoprevention Through Advanced Informatics Approaches

通过先进的信息学方法阐明SA-4-1BBL-Mediated癌症免疫预防的机制

IF4.8

2026-02-050

OAAI

Phagocytes play a critical role in the broad cancer immunoprevention efficacy of a novel agonist of CD137 pathway as a single agent

JOURNAL OF IMMUNOLOGY

IF3.4

2025-11-010

PRE

Vasoactive intestinal peptide amphiphile micelle material properties influence their cell association and internalization

MOLECULAR SYSTEMS DESIGN & ENGINEERING

IF3.2

2025-03-010

OA

Targeting apoptotic pathway to eliminate Teff cells as an effective approach to prevent acute GVHD in a humanized mouse model

TRANSPLANTATION

IF5

2024-09-160

PRE

Systemic treatment with a novel form of FasL induces tolerance to cardiac allograft in mice

TRANSPLANTATION

IF5

2024-09-160

PRE

Immunoisolation and islet survival in the absence of systemic immune suppression enabled by co-delivery of CXCL12 and FasL containing microgels in allo-islet transplanted diabetic mice

TRANSPLANTATION

IF5

2024-09-160

PRE

Engineering pancreatic islet grafts with innate immune modulators to mitigate instant blood-mediated inflammatory reaction.

TRANSPLANTATION

IF5

2024-09-160

PRE

Reversal of Diabetes by Human Stem Cell-Derived Islets Implanted with an Immunomodulatory Microgel in a Retrievable Site

IF7.5

2024-06-141

PRE

Engineering Pancreatic Islets to Transiently Codisplay on Their Surface Thrombomodulin and CD47 Immunomodulatory Proteins as a Means of Mitigating Instant Blood-Mediated Inflammatory Reaction following Intraportal Transplantation

JOURNAL OF IMMUNOLOGY

IF3.4

2024-05-065

PRE

Bending the Rules: Amplifying PD-L1 Immunoregulatory Function Through Flexible Polyethylene Glycol Synthetic Linkers

TISSUE ENGINEERING PART A

IF2.9

2024-04-012

PRE

A novel agonist of CD137 as a single agent shows cancer immunoprevention efficacy against various tumor types that is not dependent on the trained immunity

CANCER RESEARCH

IF16.6

2024-03-220

PRE

Oncolytic Adenovirus Armed with a Novel Agonist of the CD137 Immune Checkpoint Stimulator Suppresses Tumor Growth

IF3.4

2024-03-211

OAAI

Delayed graft rejection in autoimmune islet transplantation via biomaterial immunotherapy

通过生物材料免疫疗法在自身免疫性胰岛移植中的延迟移植排斥反应

AMERICAN JOURNAL OF TRANSPLANTATION

IF8.2

2023-11-017

PRE

Bioengineered omental transplant site promotes islet/cell survival in non-human primates

TRANSPLANTATION

IF5

2023-10-230

OA

Co-engineering pancreatic islets with novel forms of thrombomodulin and CD47 as an effective means of mitigating instant blood-mediated inflammatory reaction

TRANSPLANTATION

IF5

2023-10-231

OA

Engineering donor lymphocytes with Fas ligand protein effectively prevents acute graft-versus-host disease

IF7.1

2023-05-153

OAAI

Engineering pancreatic islets with a novel form of thrombomodulin protein to overcome early graft loss triggered by instant blood-mediated inflammatory reaction

AMERICAN JOURNAL OF TRANSPLANTATION

IF8.2

2023-05-014

OA

Bioengineered omental transplant site promotes pancreatic islet allografts survival in non-human

CELL REPORTS MEDICINE

IF10.6

2023-03-0110

OAAI